Nkarta Inc (NKTX)

Currency in USD
1.98
-0.03(-1.49%)
Closed·
After Hours
1.980.00(0.00%)
·
NKTX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
NKTX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
1.962.03
52 wk Range
1.316.63
Key Statistics
Prev. Close
2.01
Open
2.01
Day's Range
1.96-2.03
52 wk Range
1.31-6.63
Volume
350.65K
Average Volume (3m)
493.04K
1-Year Change
-62.29%
Book Value / Share
5.34
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NKTX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
12.80
Upside
+546.46%
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash

Nkarta Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Nkarta Inc Company Profile

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company’s lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Nkarta Inc SWOT Analysis


NK Cell Frontie
Explore Nkarta's innovative approach to cell therapy, leveraging natural killer cells for potential breakthroughs in cancer and autoimmune disease treatment
Financial Fortitude
With $427 million in cash, Nkarta is well-positioned to fund operations into late 2027, providing ample runway for clinical advancements
NKX019: Game Changer?
Delve into the potential of Nkarta's lead product, NKX019, and its advantages in safety, administration, and re-dosing capabilities
Market Valuation
Analyst price targets range from $11 to $20 per share, with a consensus "Strong Buy" recommendation, suggesting significant upside potential
Read full SWOT analysis

Compare NKTX to Peers and Sector

Metrics to compare
NKTX
Peers
Sector
Relationship
P/E Ratio
−1.3x−2.6x−0.5x
PEG Ratio
−0.04−0.050.00
Price/Book
0.4x0.9x2.6x
Price / LTM Sales
-7.0x3.3x
Upside (Analyst Target)
-318.4%43.5%
Fair Value Upside
Unlock25.9%6.8%Unlock

Analyst Ratings

6 Buy
1 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 12.80
(+546.46% Upside)

Earnings

Latest Release
May 14, 2025
EPS / Forecast
-0.43 / -0.45
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

NKTX Income Statement

People Also Watch

179.28
ALAB
+4.91%
5.29
REPL
-3.47%
46.630
ASTS
-2.26%
1.760
GOSS
+1.15%
1.040
ALLO
-0.95%

FAQ

What Stock Exchange Does Nkarta Trade On?

Nkarta is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Nkarta?

The stock symbol for Nkarta is "NKTX."

What Is the Nkarta Market Cap?

As of today, Nkarta market cap is 141.21M.

What Is Nkarta's Earnings Per Share (TTM)?

The Nkarta EPS (TTM) is -1.51.

When Is the Next Nkarta Earnings Date?

Nkarta will release its next earnings report on 04 Nov 2025.

From a Technical Analysis Perspective, Is NKTX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Nkarta Stock Split?

Nkarta has split 0 times.

How Many Employees Does Nkarta Have?

Nkarta has 109 employees.

What is the current trading status of Nkarta (NKTX)?

As of 09 Aug 2025, Nkarta (NKTX) is trading at a price of 1.98, with a previous close of 2.01. The stock has fluctuated within a day range of 1.96 to 2.03, while its 52-week range spans from 1.31 to 6.63.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.